The meeting is happening after a gap of over 30 months.
"What we are doing now in January is to meet again to do a stocktaking. It's again not a negotiation. It's a stocktaking meeting, it's the deferred meeting.
"That meeting will decide does this negotiation have a future. Hopefully in the interest of everyone it does. Then we would go ahead," Teaotia told reporters here.
Expressing disappointment and concern over the EU banning sale of around 700 pharma products, clinically tested by GVK Biosciences, India had in August deferred FTA talks with EU.
More From This Section
In May 2013, India and the 28-nation bloc failed to bridge substantial gaps on crucial issues, including data security status for IT sector.
When asked about the GVK Biosciences issue, she said: "It is going to find its logical conclusion. What we wanted was a transparent, open and fair position on that and that is under way".
"Let me clear that there were actually no negotiations underway. We have not been under negotiations for the last 3 years," she added.
The Secretary said India perceives the GVK incident as an "extremely disproportionate reaction to the perceived infringement".
"We now intend to meet," she said, adding that after the visit of German Chancellor Angela Merkel and subsequently when the "EU delegation met with us, they did give a certain level of comfort that the matter would be addressed in all fairness and that level of comfort was something acceptable".
Launched in June 2007, the negotiations for the proposed Broad-based Trade and Investment Agreement (BTIA), also known as FTA, have witnessed many hurdles with both sides having major differences on crucial issues.
The two-way commerce in goods between India and the EU stood at USD 98.5 billion in 2014-15.